CareDx (CDNA) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

CDNA Stock Forecast

CareDx stock forecast is as follows: an average price target of $37.50 (represents a 77.81% upside from CDNA’s last price of $21.09) and a rating consensus of 'Buy', based on 7 wall street analysts offering a 1-year stock forecast.

CDNA Price Target

The average price target for CareDx (CDNA) is $37.50 based on 1-year price targets from 7 Wall Street analysts in the past 3 months, with a price target range of $40.00 to $35.00. This represents a potential 77.81% upside from CDNA's last price of $21.09.

CDNA Analyst Ratings

Buy

According to 7 Wall Street analysts, CareDx's rating consensus is 'Buy'. The analyst rating breakdown for CDNA stock is 0 'Strong Buy' (0.00%), 4 'Buy' (57.14%), 2 'Hold' (28.57%), 1 'Sell' (14.29%), and 0 'Strong Sell' (0.00%).

CareDx Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Nov 05, 2024	Sung Ji Nam	BTIG	$35.00	$22.90	52.84%	65.96%
Aug 19, 2024	Mark Massaro	BTIG	$40.00	$33.00	21.21%	89.66%
Aug 16, 2024	Bill Bonello	Craig-Hallum	$40.00	$32.98	21.29%	89.66%
Aug 01, 2024	Bill Bonello	Craig-Hallum	$32.00	$19.99	60.08%	51.73%
Apr 17, 2024	Mason Carrico	Stephens	$15.00	$8.29	80.94%	-28.88%
Feb 06, 2023		Goldman Sachs	$29.00	$16.26	78.35%	37.51%
Apr 25, 2022		Stephens	$50.00	$31.72	57.63%	137.08%

The latest CareDx stock forecast, released on Nov 05, 2024 by Sung Ji Nam from BTIG, set a price target of $35.00, which represents a 52.84% increase from the stock price at the time of the forecast ($22.90), and a 65.96% increase from CDNA last price ($21.09).

CareDx Price Target by Period

	1M	3M	12M
# Anlaysts	-	1	5
Avg Price Target	-	$35.00	$32.40
Last Closing Price	$21.09	$21.09	$21.09
Upside/Downside	-100.00%	65.96%	53.63%

In the current month, the average price target of CareDx stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to CareDx's last price of $21.09. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Nov 05, 2024	BTIG	Buy	Buy	Hold
Oct 22, 2024	H.C. Wainwright	Neutral	Neutral	Hold
Aug 27, 2024	Wells Fargo		Underweight	Initialise
Aug 19, 2024	BTIG		Buy	Upgrade
Aug 01, 2024	Craig-Hallum	Buy	Buy	Hold
Jul 17, 2024	Stephens	Buy	Buy	Hold
May 17, 2024	Craig-Hallum	Buy	Buy	Hold
May 13, 2024	Stephens	Buy	Buy	Hold
May 13, 2024	Raymond James	Outperform	Market Perform	Downgrade
May 01, 2024	Craig-Hallum		Buy	Upgrade
Apr 17, 2024	Stephens	Overweight	Overweight	Hold
Nov 09, 2023	Stephens		Overweight	Upgrade
Aug 15, 2023	Raymond James	Market Perform	Outperform	Upgrade
Mar 03, 2023	Raymond James	Strong Buy	Market Perform	Downgrade
Feb 06, 2023	Goldman Sachs	Buy	Buy	Hold
Jan 31, 2023	Raymond James	Strong Buy	Strong Buy	Hold
Feb 25, 2022	Raymond James	Strong Buy	Strong Buy	Hold

CareDx's last stock rating was published by BTIG on Nov 05, 2024. The company gave CDNA a "Buy" rating, the same as its previous rate.

CareDx Financial Forecast

CareDx Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	$67.19M	$70.30M	$77.26M	$82.38M	$79.36M	$80.63M	$79.42M	$79.22M	$75.59M	$74.19M	$67.40M	$58.64M	$53.37M	$41.80M	$38.38M	$35.82M	$33.81M
Avg Forecast	$111.64M	$107.33M	$103.63M	$97.83M	$96.10M	$93.90M	$90.91M	$85.74M	$82.15M	$80.04M	$67.85M	$63.13M	$63.66M	$53.14M	$61.77M	$80.70M	$81.67M	$82.62M	$81.85M	$78.92M	$77.00M	$74.11M	$67.76M	$61.05M	$55.51M	$51.90M	$35.61M	$38.02M	$35.78M	$33.14M
High Forecast	$113.66M	$109.28M	$105.52M	$99.61M	$97.85M	$95.61M	$92.56M	$87.62M	$82.57M	$80.28M	$67.85M	$63.13M	$64.82M	$53.14M	$62.89M	$82.16M	$83.15M	$83.69M	$82.91M	$79.94M	$77.99M	$75.07M	$68.63M	$61.84M	$56.23M	$52.57M	$36.07M	$38.51M	$36.24M	$33.57M
Low Forecast	$109.79M	$105.56M	$101.92M	$96.22M	$94.51M	$92.35M	$89.41M	$84.62M	$81.84M	$79.80M	$67.85M	$63.13M	$62.61M	$53.14M	$60.75M	$79.36M	$80.32M	$81.96M	$81.20M	$78.29M	$76.38M	$73.52M	$67.22M	$60.56M	$55.07M	$51.48M	$35.32M	$37.71M	$35.49M	$32.88M
# Analysts	4	4	4	4	3	3	3	5	5	4	2	2	4	2	2	2	1	1	1	1	2	2	2	2	9	9	9	9	5	5
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	1.26%	1.14%	0.96%	1.01%	0.96%	0.99%	1.01%	1.03%	1.02%	1.09%	1.10%	1.06%	1.03%	1.17%	1.01%	1.00%	1.02%

CareDx's average Quarter revenue forecast for Dec 23 based on 4 analysts is $63.66M, with a low forecast of $62.61M, and a high forecast of $64.82M. CDNA's average Quarter revenue forecast represents a -5.26% decrease compared to the company's last Quarter revenue of $67.19M (Sep 23).

CareDx EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	4	4	4	4	3	3	3	5	5	4	2	2	4	2	2	2	1	1	1	1	2	2	2	2	9	9	9	9	5	5
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	$-28.78M	$-27.62M	$-24.33M	$-19.14M	$-13.03M	$-18.12M	$-15.55M	$-13.65M	$-9.04M	$814.00K	$1.68M	$-1.09M	$-610.00K	$-4.61M	$-3.89M	$-3.30M	$-1.30M
Avg Forecast	$-17.26M	$-16.59M	$-16.02M	$-15.12M	$-14.86M	$-14.52M	$-14.05M	$-13.26M	$-12.70M	$-12.37M	$-10.49M	$15.83M	$-9.84M	$-8.22M	$-9.55M	$16.93M	$-40.56M	$-15.10M	$-14.72M	$-14.42M	$-14.07M	$-13.54M	$-12.38M	$18.11M	$-10.14M	$-9.48M	$-6.51M	$-23.35M	$-6.54M	$-6.06M
High Forecast	$-16.97M	$-16.32M	$-15.76M	$-14.88M	$-14.61M	$-14.28M	$-13.82M	$-13.08M	$-12.65M	$-12.34M	$-10.49M	$19.00M	$-9.68M	$-8.22M	$-9.39M	$20.32M	$-32.44M	$-14.98M	$-11.78M	$-14.31M	$-13.96M	$-13.44M	$-12.28M	$21.73M	$-10.06M	$-9.41M	$-6.45M	$-18.68M	$-6.49M	$-6.01M
Low Forecast	$-17.57M	$-16.89M	$-16.31M	$-15.40M	$-15.13M	$-14.78M	$-14.31M	$-13.55M	$-12.77M	$-12.41M	$-10.49M	$12.67M	$-10.02M	$-8.22M	$-9.72M	$13.55M	$-48.67M	$-15.29M	$-17.67M	$-14.61M	$-14.25M	$-13.72M	$-12.54M	$14.49M	$-10.28M	$-9.61M	$-6.59M	$-28.02M	$-6.62M	$-6.14M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	3.50%	2.89%	-1.44%	0.47%	0.86%	1.23%	1.08%	0.97%	0.67%	-0.07%	0.09%	0.11%	0.06%	0.71%	0.17%	0.50%	0.21%

2 analysts predict CDNA's average Quarter EBITDA for Sep 21 to be $-13.54M, with a high of $-13.44M and a low of $-13.72M. This is -1763.84% lower than CareDx's previous annual EBITDA (Jun 21) of $814.00K.

CareDx Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	4	4	4	4	3	3	3	5	5	4	2	2	4	2	2	2	1	1	1	1	2	2	2	2	9	9	9	9	5	5
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	$-23.48M	$-24.95M	$-23.75M	$-18.33M	$-16.94M	$-21.70M	$-19.65M	$-16.15M	$-11.90M	$-1.93M	$-687.00K	$-3.52M	$-2.82M	$-6.56M	$-5.82M	$-4.78M	$-1.81M
Avg Forecast	$-1.06M	$264.52K	$-1.32M	$-4.23M	$-4.67M	$-5.73M	$-7.67M	$-10.14M	$-11.37M	$-13.03M	$-21.10M	$-6.49M	$-23.63M	$-31.12M	$-28.81M	$-6.94M	$-47.97M	$-20.46M	$-17.75M	$-14.35M	$-7.20M	$-7.18M	$-4.49M	$-7.42M	$-7.19M	$-10.23M	$-7.83M	$-34.94M	$-8.09M	$-7.96M
High Forecast	$-1.04M	$270.77K	$-1.29M	$-4.14M	$-4.57M	$-5.61M	$-7.51M	$-6.76M	$-9.75M	$-12.75M	$-20.65M	$-5.19M	$-23.12M	$-30.46M	$-28.19M	$-5.55M	$-38.37M	$-20.25M	$-14.20M	$-14.20M	$-7.13M	$-7.10M	$-4.44M	$-5.94M	$-7.12M	$-10.12M	$-7.75M	$-27.95M	$-8.01M	$-7.88M
Low Forecast	$-1.08M	$258.84K	$-1.35M	$-4.33M	$-4.78M	$-5.87M	$-7.85M	$-12.39M	$-11.64M	$-13.33M	$-21.60M	$-7.78M	$-24.19M	$-31.86M	$-29.49M	$-8.32M	$-57.56M	$-20.80M	$-21.30M	$-14.59M	$-7.32M	$-7.30M	$-4.56M	$-8.90M	$-7.31M	$-10.40M	$-7.96M	$-41.93M	$-8.23M	$-8.09M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.75%	0.87%	3.42%	0.38%	0.83%	1.22%	1.37%	2.24%	1.66%	0.43%	0.09%	0.49%	0.28%	0.84%	0.17%	0.59%	0.23%

CareDx's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. CDNA's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

CareDx SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	4	4	4	4	3	3	3	5	5	4	2	2	4	2	2	2	1	1	1	1	2	2	2	2	9	9	9	9	5	5
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	-	$52.44M	$50.96M	$51.26M	$48.44M	$46.09M	$52.18M	$49.71M	$45.57M	$40.04M	$35.92M	$30.68M	$29.50M	$26.99M	$24.45M	$21.73M	$19.70M	$20.54M
Avg Forecast	$66.30M	$63.74M	$61.55M	$58.10M	$57.07M	$55.77M	$53.99M	$50.92M	$48.79M	$47.53M	$40.30M	$37.49M	$37.81M	$31.56M	$36.68M	$47.93M	$48.50M	$48.76M	$42.69M	$46.57M	$45.44M	$43.73M	$39.99M	$36.02M	$32.76M	$30.63M	$21.01M	$22.43M	$21.12M	$19.56M
High Forecast	$67.51M	$64.90M	$62.67M	$59.16M	$58.11M	$56.78M	$54.97M	$52.04M	$49.04M	$47.68M	$40.30M	$37.49M	$38.49M	$31.56M	$37.35M	$48.80M	$49.38M	$49.39M	$51.23M	$47.18M	$46.02M	$44.30M	$40.50M	$36.49M	$33.18M	$31.02M	$21.28M	$22.72M	$21.39M	$19.81M
Low Forecast	$65.21M	$62.69M	$60.53M	$57.14M	$56.13M	$54.85M	$53.10M	$50.26M	$48.61M	$47.39M	$40.30M	$37.49M	$37.18M	$31.56M	$36.08M	$47.13M	$47.70M	$48.37M	$34.16M	$46.20M	$45.07M	$43.38M	$39.67M	$35.74M	$32.50M	$30.38M	$20.84M	$22.25M	$20.95M	$19.40M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	1.66%	1.39%	1.07%	1.00%	0.95%	1.22%	1.07%	1.00%	0.92%	0.90%	0.85%	0.90%	0.88%	1.16%	0.97%	0.93%	1.05%

CareDx's average Quarter SG&A projection for Dec 23 is $37.81M, based on 4 Wall Street analysts, with a range of $37.18M to $38.49M. The forecast indicates a -27.91% fall compared to CDNA last annual SG&A of $52.44M (Sep 23).

CareDx EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	4	4	4	4	3	3	3	5	5	4	2	2	4	2	2	2	1	1	1	1	2	2	2	2	9	9	9	9	5	5
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	$-0.43	$-0.00	$-0.44	$-0.34	$-0.32	$-0.41	$-0.37	$-0.31	$-0.23	$-0.04	$-0.01	$-0.07	$-0.06	$-0.15	$-0.14	$-0.11	$-0.04
Avg Forecast	$-0.02	$0.01	$-0.03	$-0.08	$-0.09	$-0.11	$-0.14	$-0.19	$-0.21	$-0.25	$-0.40	$-0.47	$-0.45	$-0.59	$-0.54	$-0.32	$-0.33	$-0.39	$-0.34	$-0.28	$-0.14	$-0.14	$-0.09	$-0.12	$-0.14	$-0.20	$-0.15	$-0.13	$-0.15	$-0.15
High Forecast	$-0.02	$0.01	$-0.02	$-0.08	$-0.09	$-0.11	$-0.14	$-0.13	$-0.18	$-0.24	$-0.39	$-0.46	$-0.44	$-0.58	$-0.53	$-0.32	$-0.33	$-0.39	$-0.34	$-0.27	$-0.14	$-0.14	$-0.09	$-0.12	$-0.14	$-0.19	$-0.15	$-0.13	$-0.15	$-0.15
Low Forecast	$-0.02	-	$-0.03	$-0.08	$-0.09	$-0.11	$-0.15	$-0.23	$-0.22	$-0.25	$-0.41	$-0.48	$-0.46	$-0.60	$-0.56	$-0.33	$-0.34	$-0.40	$-0.35	$-0.28	$-0.14	$-0.14	$-0.09	$-0.12	$-0.14	$-0.20	$-0.15	$-0.13	$-0.16	$-0.16
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.73%	0.00%	1.36%	1.02%	0.82%	1.21%	1.35%	2.25%	1.67%	0.47%	0.08%	0.51%	0.31%	1.00%	1.06%	0.71%	0.26%

According to undefined Wall Street analysts, CareDx's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to CDNA previous annual EPS of $NaN (undefined).

CareDx Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
DRIO	DarioHealth	$0.70	$10.75	1435.71%	Buy
MYGN	Myriad Genetics	$13.42	$30.20	125.04%	Hold
BDSX	Biodesix	$1.48	$3.00	102.70%	Buy
CDNA	CareDx	$21.09	$37.50	77.81%	Buy
CSTL	Castle Biosciences	$26.83	$40.50	50.95%	Buy
GH	Guardant Health	$30.44	$41.75	37.16%	Buy
EXAS	Exact Sciences	$57.55	$78.67	36.70%	Buy
PSNL	Personalis	$5.87	$7.38	25.72%	Buy
CRL	Charles River Laboratories	$186.16	$209.00	12.27%	Buy
ILMN	Illumina	$135.27	$147.78	9.25%	Buy
NTRA	Natera	$160.26	$154.80	-3.41%	Buy
TWST	Twist Bioscience	$48.17	$46.00	-4.50%	Buy

CDNA Forecast FAQ

Is CareDx a good buy?

Yes, according to 7 Wall Street analysts, CareDx (CDNA) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 4 'Buy' recommendations, accounting for 57.14% of CDNA's total ratings.

What is CDNA's price target?

CareDx (CDNA) average price target is $37.5 with a range of $35 to $40, implying a 77.81% from its last price of $21.09. The data is based on 7 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will CareDx stock go up soon?

According to Wall Street analysts' prediction for CDNA stock, the company can go up by 77.81% (from the last price of $21.09 to the average price target of $37.5), up by 89.66% based on the highest stock price target, and up by 65.96% based on the lowest stock price target.

Can CareDx stock reach $30?

CDNA's average twelve months analyst stock price target of $37.5 supports the claim that CareDx can reach $30 in the near future.

What are CareDx's analysts' financial forecasts?

CareDx's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $366.66M (high $373.64M, low $360.9M), average EBITDA is $-56.684M (high $-55.794M, low $-57.764M), average net income is $-28.215M (high $-24.447M, low $-30.896M), average SG&A $217.76M (high $221.91M, low $214.34M), and average EPS is $-0.533 (high $-0.462, low $-0.584). CDNA's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $420.43M (high $428.07M, low $413.49M), average EBITDA is $-64.998M (high $-63.924M, low $-66.179M), average net income is $-6.348M (high $-6.2M, low $-6.51M), average SG&A $249.7M (high $254.23M, low $245.57M), and average EPS is $-0.12 (high $-0.117, low $-0.123).

Did the CDNA's actual financial results beat the analysts' financial forecasts?

Based on CareDx's last annual report (Dec 2022), the company's revenue was $321.79M, which missed the average analysts forecast of $325.07M by -1.01%. Apple's EBITDA was $-77.338M, missing the average prediction of $-84.802M by -8.80%. The company's net income was $-76.613M, missing the average estimation of $-101M by -23.79%. Apple's SG&A was $196.42M, beating the average forecast of $186.53M by 5.31%. Lastly, the company's EPS was $-1.44, beating the average prediction of $-1.341 by 7.40%. In terms of the last quarterly report (Sep 2023), CareDx's revenue was $67.19M, beating the average analysts' forecast of $53.14M by 26.44%. The company's EBITDA was $-28.783M, beating the average prediction of $-8.215M by 250.35%. CareDx's net income was $-23.485M, missing the average estimation of $-31.125M by -24.55%. The company's SG&A was $52.44M, beating the average forecast of $31.56M by 66.16%. Lastly, the company's EPS was $-0.43, missing the average prediction of $-0.588 by -26.91%